Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-533,536 for closed tibial shaft fracture healing
2008-004183-38Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of evatanepag in tibial diaphyseal fracture and pseudoarthrosis (3 arms), sponsored by Pfizer. Primary endpoint: Time to fracture healing. Started Sep 2008; status: completed.
02
Drugs
evatanepag
03
Conditions
tibial diaphyseal fracturepseudoarthrosis
Beyond the preview
Go deeper on 2008-004183-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004183-38.